124 related articles for article (PubMed ID: 14766394)
1. Implantation of Spheramine in advanced Parkinson's disease (PD).
Bakay RA; Raiser CD; Stover NP; Subramanian T; Cornfeldt ML; Schweikert AW; Allen RC; Watts R
Front Biosci; 2004 Jan; 9():592-602. PubMed ID: 14766394
[TBL] [Abstract][Full Text] [Related]
2. Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease.
Watts RL; Raiser CD; Stover NP; Cornfeldt ML; Schweikert AW; Allen RC; Subramanian T; Doudet D; Honey CR; Bakay RA
J Neural Transm Suppl; 2003; (65):215-27. PubMed ID: 12946059
[TBL] [Abstract][Full Text] [Related]
3. Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease.
Stover NP; Bakay RA; Subramanian T; Raiser CD; Cornfeldt ML; Schweikert AW; Allen RC; Watts RL
Arch Neurol; 2005 Dec; 62(12):1833-7. PubMed ID: 16344341
[TBL] [Abstract][Full Text] [Related]
4. Spheramine for treatment of Parkinson's disease.
Stover NP; Watts RL
Neurotherapeutics; 2008 Apr; 5(2):252-9. PubMed ID: 18394567
[TBL] [Abstract][Full Text] [Related]
5. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease.
Hauser RA; Freeman TB; Snow BJ; Nauert M; Gauger L; Kordower JH; Olanow CW
Arch Neurol; 1999 Feb; 56(2):179-87. PubMed ID: 10025423
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patients.
Shannon KM; Penn RD; Kroin JS; Adler CH; Janko KA; York M; Cox SJ
Neurology; 1998 Feb; 50(2):434-8. PubMed ID: 9484368
[TBL] [Abstract][Full Text] [Related]
7. Disability in Activities of Daily Living and Severity of Dyskinesias Determine the Handicap of Parkinson's Disease Patients in Advanced Stage Selected to DBS.
Coelho M; Abreu D; Correia-Guedes L; Lobo PP; Fabbri M; Godinho C; Domingos J; Albuquerque L; Freitas V; Pereira JM; Cattoni B; Carvalho H; Reimão S; Rosa MM; Ferreira AG; Ferreira JJ
J Parkinsons Dis; 2017; 7(2):255-261. PubMed ID: 28157106
[TBL] [Abstract][Full Text] [Related]
8. [Bilateral pallidotomy for the treatment of advanced Parkinson disease].
Sobstyl M; Zabek M; Koziara H; Kadziołka B
Neurol Neurochir Pol; 2003; 37 Suppl 5():251-62. PubMed ID: 15098353
[TBL] [Abstract][Full Text] [Related]
9. Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up.
Ford B; Winfield L; Pullman SL; Frucht SJ; Du Y; Greene P; Cheringal JH; Yu Q; Cote LJ; Fahn S; McKhann GM; Goodman RR
J Neurol Neurosurg Psychiatry; 2004 Sep; 75(9):1255-9. PubMed ID: 15314110
[TBL] [Abstract][Full Text] [Related]
10. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease.
Moro E; Scerrati M; Romito LM; Roselli R; Tonali P; Albanese A
Neurology; 1999 Jul; 53(1):85-90. PubMed ID: 10408541
[TBL] [Abstract][Full Text] [Related]
11. Comparison of unilateral pallidotomy and subthalamotomy findings in advanced idiopathic Parkinson's disease.
Coban A; Hanagasi HA; Karamursel S; Barlas O
Br J Neurosurg; 2009 Feb; 23(1):23-9. PubMed ID: 19234905
[TBL] [Abstract][Full Text] [Related]
12. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review.
Ghika J; Villemure JG; Fankhauser H; Favre J; Assal G; Ghika-Schmid F
J Neurosurg; 1998 Nov; 89(5):713-8. PubMed ID: 9817406
[TBL] [Abstract][Full Text] [Related]
13. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease.
Slowinski JL; Putzke JD; Uitti RJ; Lucas JA; Turk MF; Kall BA; Wharen RE
J Neurosurg; 2007 Apr; 106(4):626-32. PubMed ID: 17432714
[TBL] [Abstract][Full Text] [Related]
14. Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up.
Romito LM; Scerrati M; Contarino MF; Iacoangeli M; Bentivoglio AR; Albanese A
J Neurosurg Sci; 2003 Sep; 47(3):119-28. PubMed ID: 14618124
[TBL] [Abstract][Full Text] [Related]
15. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial.
Esselink RA; de Bie RM; de Haan RJ; Lenders MW; Nijssen PC; Staal MJ; Smeding HM; Schuurman PR; Bosch DA; Speelman JD
Neurology; 2004 Jan; 62(2):201-7. PubMed ID: 14745054
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
[TBL] [Abstract][Full Text] [Related]
17. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.
Timmermann L; Jain R; Chen L; Maarouf M; Barbe MT; Allert N; Brücke T; Kaiser I; Beirer S; Sejio F; Suarez E; Lozano B; Haegelen C; Vérin M; Porta M; Servello D; Gill S; Whone A; Van Dyck N; Alesch F
Lancet Neurol; 2015 Jul; 14(7):693-701. PubMed ID: 26027940
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
19. A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL
Snow B; Mulroy E; Bok A; Simpson M; Smith A; Taylor K; Lockhart M; Lam BJ; Frampton C; Schweder P; Chen B; Finucane G; McMahon A; Macdonald L
Parkinsonism Relat Disord; 2019 Apr; 61():88-93. PubMed ID: 30503748
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.
Kaplitt MG; Feigin A; Tang C; Fitzsimons HL; Mattis P; Lawlor PA; Bland RJ; Young D; Strybing K; Eidelberg D; During MJ
Lancet; 2007 Jun; 369(9579):2097-105. PubMed ID: 17586305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
